Improving Prognostic Modeling in Myelodysplastic Syndromes Aziz NazhaMikkael A. Sekeres Myelodysplastic Syndromes (D Steensma, Section Editor) 08 August 2016 Pages: 395 - 401
Assessing Quality of Care for the Myelodysplastic Syndromes Zachary A. K. FroschGregory A. Abel Myelodysplastic Syndromes (D Steensma, Section Editor) 25 August 2016 Pages: 402 - 407
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms Charlotte K. BrierleyDavid P. Steensma Myelodysplastic Syndromes (D Steensma, Section Editor) 05 August 2016 Pages: 408 - 415
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts Anna MiesOlivier HermineUwe Platzbecker Myelodysplastic Syndromes (D Steensma, Section Editor) 05 September 2016 Pages: 416 - 424
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T Chetasi TalatiEric Padron Myelodysplastic Syndromes (D Steensma, Section Editor) 24 September 2016 Pages: 425 - 433
Palliative and End-of-Life Care in Myelodysplastic Syndromes Myles NickolichAreej El-JawahriThomas W. LeBlanc Myelodysplastic Syndromes (D Steensma, Section Editor) 04 October 2016 Pages: 434 - 440
Molecular Testing in Patients with Suspected Myelodysplastic Syndromes Tamara K. MoyoMichael R. Savona Myelodysplastic Syndromes (D Steensma, Section Editor) 12 October 2016 Pages: 441 - 448
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer Miguel-Angel PeralesEmily K. DrakeWilliam A. Wood Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 18 February 2016 Pages: 449 - 455
Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM Naveen PemmarajuAudun UtengenMichael A. Thompson Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 04 August 2016 Pages: 456 - 461
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Naveen PemmarajuVikas GuptaAndrew A. Lane Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 04 August 2016 Pages: 462 - 467
Sézary Syndrome: Clinical and Biological Aspects Rebecca KohnkenStephanie FabbroAnjali Mishra T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor) 04 October 2016 Pages: 468 - 479
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas Geetika BhattKami MaddocksBeth Christian T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor) 09 September 2016 Pages: 480 - 491
T-cell Lymphoma Epidemiology: the Known and Unknown Anh PhanRachel VeldmanMary Jo Lechowicz T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor) 20 December 2016 Pages: 492 - 503
Enteropathy-Associated T-Cell Lymphoma Sarah OndrejkaDeepa Jagadeesh T-CELL AND OTHER LYMPHOPROLIFERATIVE MALIGNANCIES (P PORCU, SECTION EDITOR) 29 November 2016 Pages: 504 - 513
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases Bradley M. HaverkosZenggang PanPierluigi Porcu T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor) 24 October 2016 Pages: 514 - 527
Acute Myeloid Leukemia: How Do We Measure Success? Joshua P. SasineGary J. Schiller Acute Myeloid Leukemias (H Erba, Section Editor) 07 September 2016 Pages: 528 - 536
Definition of Unfit for Standard Acute Myeloid Leukemia Therapy Heidi D. Klepin Acute Myeloid Leukemias (H Erba, Section Editor) 28 September 2016 Pages: 537 - 544
Antibody-Based Treatment of Acute Myeloid Leukemia Phillip M. GarfinEric J. Feldman Acute Myeloid Leukemias (H Erba, Section Editor) 12 October 2016 Pages: 545 - 552
